Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1
- 1 June 1996
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 70 (6) , 3668-77
- https://doi.org/10.1128/jvi.70.6.3668-3677.1996
Abstract
Primary isolates (PI) of human immunodeficiency virus type 1 (HIV-1) are considerably less sensitive than T-cell line-adapted strains to neutralization by soluble CD4 and by most cross-reactive monoclonal antibodies to the viral envelope (Env) glycoprotein, as well as by postinfection and postvaccination sera (J. P. Moore and D. D. Ho, AIDS 9 [suppl. A]:5117-5136, 1995). We developed a quantitative model to explain the neutralization resistance of PI. The factors incorporated into the model are the dissociation constants for the binding of the neutralizing agent to native Env oligomers, the number of outer Env molecules on the viral surface (which decreases by shedding), and the minimum number of Env molecules required for attachment and fusion. We conclude that modest differences in all these factors can, when combined, explain a relative neutralization resistance of PI versus T-cell line-adapted strains that sometimes amounts to several orders of magnitude. The hypothesis that neutralization of HIV is due to the reduction below a minimum number of the Env molecules on a virion available for attachment and fusion is at odds with single- and few-hit neutralization theories. Our analysis of these ideas favors the hypothesis that neutralization of HIV is instead a competitive blocking of interactions with cellular factors, including adsorption receptors.Keywords
This publication has 33 references indexed in Scilit:
- Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.The Journal of Experimental Medicine, 1995
- Expression and Characterization of CD4-IgG2, a Novel Heterotetramer That Neutralizes Primary HIV Type 1 IsolatesAIDS Research and Human Retroviruses, 1995
- Enhancement of Infectivity of a Non‐Syncytium Inducing HIV‐1 by sCD4 and by Human Antibodies that Neutralize Syncytium Inducing HIV‐1Scandinavian Journal of Immunology, 1995
- A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 1994
- Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal AntibodyScience, 1994
- Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodiesJournal of General Virology, 1994
- Soluble CD4 and CD4 Immunoglobulin-Selected HIV-1 Variants: A Phenotypic CharacterizationAIDS Research and Human Retroviruses, 1993
- Adaptation of Two Primary Human Immunodeficiency Virus Type 1 Isolates to Growth in Transformed T Cell Lines Correlates with Alterations in the Responses of Their Envelope Glycoproteins to Soluble CD4AIDS Research and Human Retroviruses, 1993
- Thermodynamic and Kinetic Analysis of sCD4 Binding to HIV-1 Virions and of gp120 DissociationAIDS Research and Human Retroviruses, 1992
- Blocking of HIV-1 Infectivity by a Soluble, Secreted Form of the CD4 AntigenScience, 1987